Continuing our Life-Long Commitment to Rare Disease Patients Around the World
As our global community continues to navigate the impact of COVID-19, CENTOGENE remains fully open and operational, underlining our continued commitment to patients globally.
ORDER ON CENTOPORTAL®

Back
Img Alt Text

Transforming Global Genetic Data into Medical Decisions

We are a global leader in rare disease diagnosis and research by transforming real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

CENTOGENE’S LATEST SCIENTIFIC PUBLICATIONS & WEBINARS

Cómo los biomarcadores transforman los diagnósticos genéticos

A lo largo del seminario web, Pilar Guatibonza, MD, y Carlos Manrique, MD, bindarán una…

How Biomarkers Transform Genetic Diagnostics: Fast and Precise Answers for…

Throughout the webinar, Dr. Tobias Böttcher will provide an overview of how multiomic…

生殖健康与產前遺傳学檢測

臨床遺傳學協調員盧佳韻會詳細論述 CENTOGENE 的產前篩查選項,以及產前檢測如何在孕週期時發揮關鍵作用,快速尋找答案。

One Gene – Two Modes if Inheritance

While most genetic disorders have one clearly defined mode of inheritance, the existence…

Six Novel Gene-Disease Associations

While technology has advanced over the past ten years, more than half of patients with…

Recognition of CENTOGENE's Scientific Expertise

Review articles constitute a unique type of scientific publication, as they summarize,…

A Genetic Cause for Infectious Disease

While infectious diseases are commonly connected to environmental factors, genetic defects…

The Importance of Neuronal Membrane Biology

Nerve cells have a uniquely large surface-to-volume ratio, suggesting a central role for…

A Dispute on Rare Disease Diagnostic Offerings

CENTOGENE was amongst the first providers of diagnostic Whole Genome Sequencing (WGS) and…

An Unusual Kind of Repeat Expansion Disorder

Repeat expansions are the cause of Huntington’s disease and several forms of ataxia. The…

Company Newsletter

Keep up to date with the latest scientific insights and rare disease news
with your monthly digital edition of CentoBrief

Subscribe Now

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 12. Mai 2021

  • CENTOGENE erweitert sein Test-Angebot am Düsseldorfer Flughafen um den...
Read more

Providing patients with genetic testing designed to accelerate the diagnosis and personalized treatment of Parkinson’s disease (PD)

Read more

CENTOGENE’s rare disease mutation database offers new features and previously unpublished variants

Read more

Research leads to diagnosis and treatment options for rare disease patients

Read more

Delivers very strong financial results in unprecedented year

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 14, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, April 8, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare...

Read more

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 9, 2021 (GLOBE NEWSWIRE)

  • Rostock International Parkinson's Disease (ROPAD) Study aims to characterize...
Read more

ERLÄUTERUNG ZUR PRESSEMITTEILUNG: CENTOGENE ENTDECKT BEI DER SEQUENZIERUNG POSITIVER BEFUNDE SELTENE SARS-COV-2 VARIANTE B.1.525 ERSTMALS IN DEUTSCHLAND

wir...

Read more